T6	Exp 17 53	the hypersensitive site HS2 enhancer
T7	Exp 78 94	the human genome
T8	Exp 96 151	the erythroid-specific hypersensitive site HS2 enhancer
T9	Exp 162 179	the transcription
T10	Exp 183 220	the downstream beta-like globin genes
T11	Exp 243 256	The mechanism
T12	Exp 296 313	The present study
T13	Exp 355 381	the transcriptional status
T14	Exp 385 401	the HS2 enhancer
T15	Exp 506 511	which
T16	Exp 608 612	that
T17	Exp 512 528	the HS2 enhancer
T18	Exp 540 556	the HS2 sequence
T19	Exp 565 578	the synthesis
T20	Exp 650 662	the enhancer
T21	Exp 685 704	the intervening DNA
T22	Exp 710 733	the cis-linked CAT gene
T23	Exp 766 771	which
T24	Exp 772 788	the HS2 enhancer
T25	Exp 858 874	the HS2 enhancer
T26	Exp 914 927	the synthesis
T27	Exp 1042 1065	the cis-linked CAT gene
T28	Exp 1333 1337	they
T29	Exp 1327 1332	where
T30	Exp 1080 1093	the synthesis
T31	Exp 1109 1128	the intervening DNA
T32	Exp 1133 1141	the gene
T33	Exp 1185 1201	the HS2 enhancer
T34	Exp 1218 1241	the chromatin structure
T35	Exp 1305 1326	the promoter sequence
T36	Exp 1352 1369	the transcription
T37	Exp 1373 1381	the gene
T38	Exp 1385 1397	the cap site
R7	Coref Anaphora:T15 Antecedent:T39
R8	Coref Anaphora:T16 Antecedent:T40
R9	Coref Anaphora:T23 Antecedent:T41
R10	Coref Anaphora:T32 Antecedent:T27
R11	Coref Anaphora:T37 Antecedent:T27
R12	Coref Anaphora:T29 Antecedent:T35
R13	Coref Anaphora:T28 Antecedent:T42
T1	Protein 198 214	beta-like globin
T2	Protein 429 462	chloramphenicol acetyltransferase
T3	Protein 464 467	CAT
T4	Protein 725 728	CAT
T5	Protein 1057 1060	CAT
T39	Exp 482 502	erythroid K562 cells
T40	Exp 582 607	long enhancer transcripts
T41	Exp 738 762	nonerythroid HL-60 cells
T42	Exp 1276 1301	enhancer binding proteins
